Loading...

Imagin Medical

DB:DPD2
Snowflake Description

Flawless balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
DPD2
DB
CA$9M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Imagin Medical Inc. engages in developing imaging solutions for the early detection of cancer through the use of endoscopes. The last earnings update was 22 days ago. More info.


Add to Portfolio Compare Print
  • Imagin Medical has significant price volatility in the past 3 months.
DPD2 Share Price and Events
7 Day Returns
-15.2%
DB:DPD2
3.1%
DE Medical Equipment
1.5%
DE Market
1 Year Returns
-76.6%
DB:DPD2
17.1%
DE Medical Equipment
-5.8%
DE Market
DPD2 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Imagin Medical (DPD2) -15.2% -14.7% -26.6% -76.6% -57.3% -
DE Medical Equipment 3.1% 5.1% 6.8% 17.1% 109.3% 235.7%
DE Market 1.5% 1.3% 2.2% -5.8% 17.6% 8.7%
1 Year Return vs Industry and Market
  • DPD2 underperformed the Medical Equipment industry which returned 17.1% over the past year.
  • DPD2 underperformed the Market in Germany which returned -5.8% over the past year.
Price Volatility
DPD2
Industry
5yr Volatility vs Market

Value

 Is Imagin Medical undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Imagin Medical. This is due to cash flow or dividend data being unavailable. The share price is €0.0367.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Imagin Medical's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Imagin Medical's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:DPD2 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in CAD CA$-0.04
CNSX:IME Share Price ** CNSX (2019-06-25) in CAD CA$0.07
Germany Medical Equipment Industry PE Ratio Median Figure of 10 Publicly-Listed Medical Equipment Companies 32.05x
Germany Market PE Ratio Median Figure of 425 Publicly-Listed Companies 19.8x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Imagin Medical.

DB:DPD2 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:IME Share Price ÷ EPS (both in CAD)

= 0.07 ÷ -0.04

-1.57x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Imagin Medical is loss making, we can't compare its value to the DE Medical Equipment industry average.
  • Imagin Medical is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Imagin Medical's expected growth come at a high price?
Raw Data
DB:DPD2 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.57x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Germany Medical Equipment Industry PEG Ratio Median Figure of 7 Publicly-Listed Medical Equipment Companies 2.67x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.45x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Imagin Medical, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Imagin Medical's assets?
Raw Data
DB:DPD2 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in CAD CA$0.03
CNSX:IME Share Price * CNSX (2019-06-25) in CAD CA$0.07
Germany Medical Equipment Industry PB Ratio Median Figure of 13 Publicly-Listed Medical Equipment Companies 4.33x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.8x
DB:DPD2 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:IME Share Price ÷ Book Value per Share (both in CAD)

= 0.07 ÷ 0.03

2.13x

* Primary Listing of Imagin Medical.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Imagin Medical is good value based on assets compared to the DE Medical Equipment industry average.
X
Value checks
We assess Imagin Medical's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Imagin Medical has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Imagin Medical expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Imagin Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.5%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Imagin Medical expected to grow at an attractive rate?
  • Unable to compare Imagin Medical's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Imagin Medical's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Imagin Medical's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:DPD2 Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 12.5%
Germany Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:DPD2 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:DPD2 Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-03-31 -4 -6
2018-12-31 -4 -8
2018-09-30 -5 -8
2018-06-30 -4 -6
2018-03-31 -3 -5
2017-12-31 -1 -2
2017-09-30 -1 -2
2017-06-30 -1 -2
2017-03-31 -1 -2
2016-12-31 -2 -3
2016-09-30 -1 -2
2016-06-30 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Imagin Medical is high growth as no earnings estimate data is available.
  • Unable to determine if Imagin Medical is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:DPD2 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Imagin Medical Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:DPD2 Past Financials Data
Date (Data in CAD Millions) EPS *
2019-03-31 -0.04
2018-12-31 -0.06
2018-09-30 -0.07
2018-06-30 -0.06
2018-03-31 -0.07
2017-12-31 -0.04
2017-09-30 -0.03
2017-06-30 -0.04
2017-03-31 -0.04
2016-12-31 -0.05
2016-09-30 -0.05
2016-06-30 -0.04

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Imagin Medical will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Imagin Medical's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Imagin Medical's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Imagin Medical's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Imagin Medical's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Imagin Medical has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Imagin Medical performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Imagin Medical's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Imagin Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Imagin Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Imagin Medical's 1-year growth to the DE Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Imagin Medical's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Imagin Medical Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:DPD2 Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 -5.91 4.40 1.39
2018-12-31 -7.70 6.44 1.12
2018-09-30 -7.96 7.03 0.81
2018-06-30 -6.11 5.53 0.51
2018-03-31 -4.66 4.28 0.29
2017-12-31 -2.32 2.03 0.22
2017-09-30 -1.54 1.13 0.33
2017-06-30 -1.82 1.28 0.45
2017-03-31 -2.16 1.59 0.49
2016-12-31 -2.68 1.84 0.37
2016-09-30 -2.26 1.57 0.24
2016-06-30 -1.71 1.18 0.11
2015-09-30 -0.10 0.10

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Imagin Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Imagin Medical has efficiently used its assets last year compared to the DE Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Imagin Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Imagin Medical's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Imagin Medical has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Imagin Medical's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Imagin Medical's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Imagin Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Imagin Medical has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Imagin Medical's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Imagin Medical has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Imagin Medical Company Filings, last reported 2 months ago.

DB:DPD2 Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 4.58 0.00 4.51
2018-12-31 5.51 0.00 5.37
2018-09-30 5.99 0.00 5.82
2018-06-30 6.88 0.00 6.05
2018-03-31 3.86 0.00 3.15
2017-12-31 1.78 0.04 1.61
2017-09-30 -0.51 0.10 0.25
2017-06-30 -0.47 0.12 0.01
2017-03-31 -0.19 0.12 0.03
2016-12-31 0.19 0.00 0.08
2016-09-30 0.13 0.00 0.07
2016-06-30 0.45 0.00 0.22
2015-09-30 0.00 0.00 0.00
  • Imagin Medical has no debt.
  • Imagin Medical currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Imagin Medical has sufficient cash runway for 1.2 years based on current free cash flow.
  • Imagin Medical has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 53.7% each year.
X
Financial health checks
We assess Imagin Medical's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Imagin Medical has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Imagin Medical's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Imagin Medical dividends.
If you bought €2,000 of Imagin Medical shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Imagin Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Imagin Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:DPD2 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 328 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Imagin Medical has not reported any payouts.
  • Unable to verify if Imagin Medical's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Imagin Medical's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Imagin Medical has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Imagin Medical's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Imagin Medical afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Imagin Medical has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Imagin Medical's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jim Hutchens
COMPENSATION CA$1,643,857
TENURE AS CEO 3.3 years
CEO Bio

Mr. Edward James Hutchens, also known as Jim, is the Co-founder and Managing Director of Origin Partners. Mr. Hutchens has been Chief Executive Officer and President of Imagin Medical Inc. since February 2016. He was the Founder and Chief Executive Officer of Microsurge, Inc. Mr. Hutchens served as Chief Executive Officer of Choice Therapeutics, Inc., until May 5, 2014. He held senior positions at Boston Scientific, Smith & Nephew, Millipore, CR Bard and Microsurge. At Boston Scientific, Mr. Hutchens was a Senior Executive at the Microvasive Division. Mr. Hutchens has over 30 years of high level operating and entrepreneurial experience in medical technology. He was also a key driver in the successful launch and ongoing management of new products and product lines that generated millions of dollars in sales and profits. He has been a Director of Imagin Medical Inc. since February 9, 2016. He served as a Director of MediSpectra, Inc. He served as a Director at LexaGene Holdings Inc. since October 12, 2016 until June 26, 2017. He holds a B.S. in Business Administration from Boston University.

CEO Compensation
  • Jim's compensation has increased whilst company is loss making.
  • Jim's remuneration is higher than average for companies of similar size in Germany.
Management Team

Jim Hutchens

TITLE
CEO, President & Director
COMPENSATION
CA$2M
TENURE
3.3 yrs

John Vacha

TITLE
CFO, Corporate Secretary & Director
COMPENSATION
CA$260K
TENURE
1.4 yrs

Thom McMahon

TITLE
Director of Sales
Board of Directors Tenure

Average tenure of the Imagin Medical board of directors in years:

2.7
Average Tenure
  • The average tenure for the Imagin Medical board of directors is less than 3 years, this suggests a new board.
Board of Directors

Robin Atlas

TITLE
Chairperson
COMPENSATION
CA$6K
AGE
66

Jim Hutchens

TITLE
CEO, President & Director
COMPENSATION
CA$2M
TENURE
3.3 yrs

John Vacha

TITLE
CFO, Corporate Secretary & Director
COMPENSATION
CA$260K
TENURE
1.4 yrs

Ralph de Vere White

TITLE
Chairman of Scientific Medical Advisory Board
TENURE
3.2 yrs

Edward Messing

TITLE
Member of Scientific Medical Advisory Board
TENURE
2.8 yrs

Ken Daignault

TITLE
Director
COMPENSATION
CA$38K
TENURE
2.8 yrs

Liam Hurley

TITLE
Member of Scientific Medical Advisory Board
TENURE
2.7 yrs

Roger Buckley

TITLE
Member of Scientific Medical Advisory Board
TENURE
2.6 yrs

Chris Bleck

TITLE
Director
AGE
61
TENURE
0.7 yrs

Ashish Kamat

TITLE
Member of Scientific Advisory Board
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Imagin Medical individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
18. Jun 19 Buy Christopher Bleck Individual 18. Jun 19 18. Jun 19 83,472 €0.05 €4,463
12. Jun 19 Buy Kenneth Daignault Individual 12. Jun 19 12. Jun 19 82,236 €0.06 €4,918
12. Jun 19 Buy John Vacha Individual 12. Jun 19 12. Jun 19 72,000 €0.06 €4,214
12. Jun 19 Buy Edward Hutchens Individual 12. Jun 19 12. Jun 19 100,000 €0.06 €5,488
X
Management checks
We assess Imagin Medical's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Imagin Medical has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Imagin Medical Inc. engages in developing imaging solutions for the early detection of cancer through the use of endoscopes. Its ultrasensitive imaging technology is based on improved optical designs and advanced light sensors for detecting cancer, as well as visualize, identify, and remove cancerous cells. The company’s target market is bladder cancer. Imagin Medical Inc. is headquartered in Vancouver, Canada.

Details
Name: Imagin Medical Inc.
DPD2
Exchange: DB
Founded:
CA$6,009,048
139,060,278
Website: http://imaginmedical.com
Address: Imagin Medical Inc.
890 West Pender Street,
Suite 600,
Vancouver,
British Columbia, V6C 1L9,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX IME Common Shares Canadian National Stock Exchange CA CAD 11. Feb 2016
DB DPD2 Common Shares Deutsche Boerse AG DE EUR 11. Feb 2016
Number of employees
Current staff
Staff numbers
0
Imagin Medical employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/25 21:21
End of day share price update: 2019/06/25 00:00
Last earnings filing: 2019/06/03
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/09/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.